Switch to:
Allergan PLC (NYSE:AGN)
Enterprise Value
$164,595 Mil (As of Today)

Think of enterprise value as the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents.

EV/EBIT ratio is calculated as enterprise value divided by its EBIT. As of today, Allergan PLC's enterprise value is $164,595 Mil. Allergan PLC's earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2015 was $-2,032 Mil. Therefore, Allergan PLC's EV/EBIT ratio for today is -80.99.

EV/EBITDA ratio is calculated as enterprise value divided by its EBITDA. As of today, Allergan PLC's enterprise value is $164,595 Mil. Allergan PLC's earnings before depreciation and amortization for the trailing twelve months (TTM) ended in Mar. 2015 was $1,299 Mil. Therefore, Allergan PLC's EV/EBITDA ratio for today is 126.72.

EV/Revenue ratio is calculated as enterprise value divided by its Revenue. As of today, Allergan PLC's enterprise value is $164,595 Mil. Allergan PLC's revenue for the trailing twelve months (TTM) ended in Mar. 2015 was $14,641 Mil. Therefore, Allergan PLC's EV/Revenue ratio for today is 11.24.


Definition

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents.

Allergan PLC's Enterprise Value for the fiscal year that ended in Dec. 2014 is calculated as

Enterprise Value (A: Dec. 2014 )
=Market Cap+Preferred Stock+Long-Term Debt
=68445.319+0+14846.3
+Short-Term Debt Without Lease+Minority Interest-Cash and Cash Equivalents
+0+4.4-251
=83,045

Allergan PLC's Enterprise Value for the quarter that ended in Mar. 2015 is calculated as

Enterprise Value (Q: Mar. 2015 )
=Market Cap+Preferred Stock+Long-Term Debt
=116756.326+4929.7+42700.5
+Short-Term Debt Without Lease+Minority Interest-Cash and Cash Equivalents
+0+4.7-2130.9
=162,260

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of enterprise value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV/EBIT ratio is calculated as enterprise value divided by its EBIT.

Allergan PLC's EV/EBIT for today is

Allergan PLC's current Enterprise Value is $164,595 Mil.
Allergan PLC's Earnings Before Interest and Taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2015 was 171.5 (Jun. 2014 ) + -1018.6 (Sep. 2014 ) + -667.1 (Dec. 2014 ) + -518.1 (Mar. 2015 ) = $-2,032 Mil.

2. EV/EBITDA ratio is calculated as enterprise value divided by its EBITDA.

Allergan PLC's EV/EBITDA for today is:

Allergan PLC's current Enterprise Value is $164,595 Mil.
Allergan PLC's Earnings Before Depreciation and Amortization for the trailing twelve months (TTM) ended in Mar. 2015 was 643.9 (Jun. 2014 ) + -80.4 (Sep. 2014 ) + 270.9 (Dec. 2014 ) + 464.5 (Mar. 2015 ) = $1,299 Mil.

3. EV/Revenue ratio is calculated as enterprise value divided by its Revenue.

Allergan PLC's EV/Revenue for today is:

EV/Revenue ratio=Enterprise Value (Today)/Revenue (TTM)
=164595.250/14641.4
=11.24

Allergan PLC's current Enterprise Value is $164,595 Mil.
Allergan PLC's Earnings Before Depreciation and Amortization for the trailing twelve months (TTM) ended in Mar. 2015 was 2667.2 (Jun. 2014 ) + 3683.1 (Sep. 2014 ) + 4056.9 (Dec. 2014 ) + 4234.2 (Mar. 2015 ) = $14,641 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Related Terms

Market Cap, Preferred Stock, Long-Term Debt, Cash and Cash Equivalents


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Allergan PLC Annual Data

Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14
ev 3,5713,7383,5033,1376,1317,2218,29816,93437,45783,045

Allergan PLC Quarterly Data

Dec12Mar13Jun13Sep13Dec13Mar14Jun14Sep14Dec14Mar15
ev 16,93417,86422,75624,55337,45744,01645,37478,69783,045162,260
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK